Glenn Pierce

Investor

Investment Committee Co-Chair at Pathway to Cures

About

Pierce is an independent consultant and entrepreneur-in-residence at Third Rock Ventures with 30 years of biotech R&D experience. He retired from Biogen in 2014 as SVP of Hematology, Cell and Gene Therapies.

Colleagues at Pathway to Cures

Amy L. Dunn

Chair, Medical and Scientific Advisory Council (MASAC) for NBDF at Pathway to Cures

Beth Whitehouse

NBDF Senior Vice President for Advancement at Pathway to Cures

Brian Andrew

Investment Committee Chair at Pathway to Cures

Christine Brennan

Investment Committee Member at Pathway to Cures

Geeta Vemuri

Managing Partner, Founder at Agent Capital

Gilbert C. White

P2C Board Vice Chair & Secretary at Pathway to Cures

Gilbert C. White, II

P2C Board Vice Chair & Secretary at Pathway to Cures

Haiyan Jiang

Scientific Advisory Group Member at Pathway to Cures